(ASND) Ascendis Pharma AS - Performance 9.2% in 12m
Compare ASND with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
5.18%
#33 in Group
Rel. Strength
65.94%
#2726 in Universe
Total Return 12m
9.19%
#41 in Group
Total Return 5y
19.40%
#35 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -3.71%
(?) Percentile in Group
12m Total Return: ASND (9.2%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ASND vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
Total Return (including Dividends) | ASND | XBI | S&P 500 |
---|---|---|---|
1 Month | -5.86% | -10.94% | -6.73% |
3 Months | 24.04% | -14.92% | -11.93% |
12 Months | 9.19% | -6.46% | 7.24% |
5 Years | 19.40% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | ASND | XBI | S&P 500 |
1 Month | 17.0% | -52.8% | -63.5% |
3 Months | 61.0% | -92.8% | -90.3% |
12 Months | 34.1% | -32.4% | 60.6% |
5 Years | -24.4% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #79 | 5.70% | 0.93% |
3 Month | #13 | 45.8% | 40.8% |
12 Month | #43 | 16.7% | 1.82% |
5 Years | #35 | 47.8% | -40.5% |
FAQs
Does ASND Ascendis Pharma AS outperforms the market?
Yes,
over the last 12 months ASND made 9.19%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ASND made 24.04%, while XBI made -14.92%.
Over the last 3 months ASND made 24.04%, while XBI made -14.92%.
Performance Comparison ASND vs Indeces and Sectors
ASND vs. Indices ASND is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -1.87% | 0.87% | 30.6% | 1.95% |
US NASDAQ 100 | QQQ | -2.35% | 1.50% | 30.5% | 1.60% |
US Dow Jones Industrial 30 | DIA | 0.16% | 1.05% | 30.0% | 4.70% |
German DAX 40 | DAX | -3.09% | -1.92% | 10.7% | -11.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.30% | -2.47% | 29.5% | -0.02% |
Hongkong Hang Seng | HSI | -4.54% | -2.14% | 26.1% | -7.59% |
India NIFTY 50 | INDA | -4.02% | -7.89% | 27.3% | 6.20% |
Brasil Bovespa | EWZ | -6.14% | -6.32% | 25.6% | 17.9% |
ASND vs. Sectors ASND is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.58% | 0.99% | 21.5% | -5.88% |
Consumer Discretionary | XLY | -3.31% | 0.98% | 25.3% | -2.10% |
Consumer Staples | XLP | -2.02% | -8.84% | 22.7% | -2.14% |
Energy | XLE | -1.94% | 6.64% | 31.9% | 21.9% |
Financial | XLF | -2.57% | -1.01% | 21.8% | -8.64% |
Health Care | XLV | 0.40% | 1.90% | 32.8% | 11.6% |
Industrial | XLI | -1.27% | 0.17% | 30.8% | 5.13% |
Materials | XLB | -1.61% | -0.01% | 37.9% | 15.1% |
Real Estate | XLRE | -1.64% | -2.63% | 31.0% | -5.54% |
Technology | XLK | -2.14% | 3.14% | 36.9% | 8.03% |
Utilities | XLU | -1.76% | -6.06% | 27.0% | -12.5% |
Aerospace & Defense | XAR | -0.42% | -2.68% | 21.3% | -12.7% |
Biotech | XBI | -5.29% | 5.08% | 42.0% | 15.7% |
Homebuilder | XHB | -3.40% | 2.26% | 45.4% | 19.7% |
Retail | XRT | -3.74% | -0.47% | 34.1% | 15.5% |